atherosclerosis. Atherosclerotic heart disease
Conditions
Interventions
Intervention 1: Intervention group:Patients in the intervention group received 1200 µg / min propofol by syringe pump as a cardioplegic solution. Intervention 2: Control group: Patients in the contro
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patient who are candidate for elective Coronary Artery Bypass surgery
Exclusion criteria
Exclusion criteria: Redo surgery Primary troponin level is above 3 µg / L sever Renal failure sever Liver failure congestive Heart Failure grade IV Ejection fraction lower than 30% Allergy to eggs, soy, peanuts
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of troponin I. Timepoint: 1st sample just after induction ,2nd sample just after chest closure , 3rd sample 6 hours after arrival to ICU and last sample 24 hours after arrival to the ICU. Method of measurement: Lab test.;Serum level of CPKMB. Timepoint: 1st sample just after induction ,2nd sample just after chest closure , 3rd sample 6 hours after arrival to ICU and last sample 24 hours after arrival to the ICU. Method of measurement: Lab test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Arhytmia. Timepoint: During operation and after that. Method of measurement: Monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGholam Ali Heidari kochi
Shiraz University of Medical Sciences
Outcome results
None listed